{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T17:40:46Z","timestamp":1773510046564,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T00:00:00Z","timestamp":1714435200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.heliyon.2024.e30606","type":"journal-article","created":{"date-parts":[[2024,5,4]],"date-time":"2024-05-04T20:11:22Z","timestamp":1714853482000},"page":"e30606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4196-985X","authenticated-orcid":false,"given":"Leanne","family":"Dooley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Ozberk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Good","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kotiw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.heliyon.2024.e30606_bib1","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis","year":"2005","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.heliyon.2024.e30606_bib2","first-page":"1","article-title":"Group a streptococcal diseases and their global burden. Current topics in microbiology and immunology","volume":"368","author":"Ralph","year":"2013"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e30606_bib4","first-page":"713","article-title":"Global, regional, and national Burden of rheumatic heart disease, 1990\u20132015. New england journal of medicine","volume":"377","author":"Watkins","year":"2017"},{"issue":"119 Suppl","key":"10.1016\/j.heliyon.2024.e30606_bib5","first-page":"148","article-title":"Invasive group A streptococcal disease in North Queensland","volume":"2004","author":"Norton","year":"1996","journal-title":"Indian J. Med. Res."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30606_bib6","first-page":"102740","article-title":"Rheumatic heart disease: a review of the current status of global research activity. Autoimmunity Reviews","volume":"20","author":"Dooley","year":"2021"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30606_bib7","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0012-2018","article-title":"Surface proteins on gram-positive bacteria","volume":"7","author":"Fischetti","year":"2019","journal-title":"Microbiol. Spectr."},{"issue":"8923","key":"10.1016\/j.heliyon.2024.e30606_bib8","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(94)92083-4","article-title":"Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein","volume":"344","author":"Pruksakorn","year":"1994","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.heliyon.2024.e30606_bib9","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.1700836","article-title":"Enhancing vaccine efficacy by engineering a complex synthetic peptide to become a super immunogen","volume":"199","author":"Nordstrom","year":"2017","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30606_bib10","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.copbio.2007.10.013","article-title":"Virus-like particles-universal molecular toolboxes","volume":"18","author":"Ludwig","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30606_bib11","doi-asserted-by":"crossref","first-page":"46621","DOI":"10.1038\/srep46621","article-title":"Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine","volume":"7","author":"Collins","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30606_bib12","first-page":"59","article-title":"Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. Journal of Nanobiotechnology","volume":"19","author":"Nooraei","year":"2021"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e30606_bib13","first-page":"151","article-title":"A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS\/S hepatitis B vaccine Sci-B-Vac\u2122, as compared to Engerix B(\u00ae), among vaccine na\u00efve and vaccine non-responder dialysis patients. Clin Exp Nephrol","volume":"22","author":"Elhanan","year":"2018"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e30606_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033235","article-title":"Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine","volume":"7","author":"Mulder","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30606_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1128\/CVI.05295-11","article-title":"Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model","volume":"19","author":"Kotiw","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e30606_bib16","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.vaccine.2013.02.042","article-title":"Hepatitis B virus-like particles access major histocompatibility class I and II antigen presentation pathways in primary dendritic cells","volume":"31","author":"Moffat","year":"2013","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.heliyon.2024.e30606_bib17","doi-asserted-by":"crossref","first-page":"7770","DOI":"10.1016\/S0021-9258(18)34448-X","article-title":"Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins","volume":"257","author":"Gavilanes","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e30606_bib18","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.39097","article-title":"Impacts of the G145R mutation on the structure and immunogenic activity of the hepatitis B surface antigen: a computational analysis","volume":"16","author":"Rezaee","year":"2016","journal-title":"Hepat. Mon."},{"issue":"14","key":"10.1016\/j.heliyon.2024.e30606_bib19","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.79.14.4400","article-title":"Immune response to synthetic peptide analogues of hepatitis B surface antigen specific for the a determinant","volume":"79","author":"Bhatnagar","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e30606_bib20","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1128\/JVI.75.5.2130-2141.2001","article-title":"Antigenicity and immunogenicity of novel chimeric hepatitis B surface antigen particles with exposed hepatitis C virus epitopes","volume":"75","author":"Netter","year":"2001","journal-title":"J. Virol."},{"issue":"1\u20132","key":"10.1016\/j.heliyon.2024.e30606_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jim.2006.03.008","article-title":"Evaluation of murine monoclonal antibodies targeting different epitopes of the hepatitis B virus surface antigen by using immunological as well as molecular biology and biochemical approaches","volume":"313","author":"Alves Vianna","year":"2006","journal-title":"J. Immunol. Methods"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e30606_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jviromet.2003.10.002","article-title":"Quantitation of hepatitis B surface antigen by an automated chemiluminescent microparticle immunoassay","volume":"115","author":"Deguchi","year":"2004","journal-title":"J. Virol Methods"},{"issue":"6","key":"10.1016\/j.heliyon.2024.e30606_bib23","first-page":"1305","article-title":"Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol","volume":"118","author":"Huovila","year":"1992"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e30606_bib24","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4155\/tde.14.74","article-title":"Antigen delivery by virus-like particles for immunotherapeutic vaccination","volume":"5","author":"Al-Barwani","year":"2014","journal-title":"Ther. Deliv."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e30606_bib25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/wnan.1336","article-title":"Development of virus-like particles for diagnostic and prophylactic biomedical applications. Wiley interdisciplinary reviews","volume":"7","author":"Schwarz","year":"2015","journal-title":"Nanomedicine and nanobiotechnology"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024066374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024066374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T01:45:21Z","timestamp":1758678321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024066374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":24,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2405844024066374"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30606","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chimeric hepatitis B surface antigen virus-like particles expressing the strep A epitope p*17 elicit a humoral immune response in mice","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e30606","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e30606"}}